BCAB
Income statement / Annual
Last year (2025), BioAtla Inc's total revenue was $2.00 M,
a decrease of 81.82% from the previous year.
In 2025, BioAtla Inc's net income was -$59.61 M.
See BioAtla Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$2.00 M |
$11.00 M |
$0.00 |
$0.00 |
$250.00 K |
$429.00 K |
$5.20 M |
$10.63 M |
| Cost of Revenue |
$0.00
|
$925.00 K
|
$1.22 M
|
$1.20 M
|
$0.00
|
$19.93 M
|
$25.92 M
|
$26.31 M
|
| Gross Profit |
$2.00 M
|
$10.08 M
|
-$1.22 M
|
-$1.20 M
|
$250.00 K
|
-$19.50 M
|
-$20.72 M
|
-$15.68 M
|
| Gross Profit Ratio |
1
|
0.92
|
0
|
0
|
1
|
-45.46
|
-3.98
|
-1.48
|
| Research and Development Expenses |
$43.57 M
|
$63.10 M
|
$103.73 M
|
$79.35 M
|
$58.27 M
|
$19.93 M
|
$25.92 M
|
$26.31 M
|
| General & Administrative Expenses |
$17.73 M
|
$21.85 M
|
$25.96 M
|
$28.79 M
|
$38.42 M
|
$10.60 M
|
$7.55 M
|
$12.56 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$17.73 M
|
$21.85 M
|
$25.96 M
|
$28.79 M
|
$38.42 M
|
$10.60 M
|
$7.55 M
|
$12.56 M
|
| Other Expenses |
$0.00
|
-$925.00 K
|
-$1.22 M
|
-$1.20 M
|
$0.00
|
-$19.93 M
|
-$25.92 M
|
-$5.00 K
|
| Operating Expenses |
$61.31 M
|
$84.02 M
|
$128.47 M
|
$106.94 M
|
$96.69 M
|
$10.60 M
|
$7.55 M
|
$38.86 M
|
| Cost And Expenses |
$61.31 M
|
$84.94 M
|
$129.69 M
|
$108.14 M
|
$96.69 M
|
$30.53 M
|
$33.47 M
|
$38.86 M
|
| Interest Income |
$843.00 K
|
$3.37 M
|
$6.31 M
|
$1.65 M
|
$350.00 K
|
$100.00 K
|
$128.00 K
|
$209.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.00 K
|
$1.39 M
|
$1.63 M
|
$949.00 K
|
| Depreciation & Amortization |
$373.00 K
|
$925.00 K
|
$1.22 M
|
$1.20 M
|
$1.33 M
|
$1.01 M
|
$860.00 K
|
$794.00 K
|
| EBITDA |
-$58.93 M |
-$73.02 M |
-$122.24 M |
-$105.28 M |
-$94.07 M |
-$33.46 M |
-$27.41 M |
-$27.24 M |
| EBITDA Ratio |
-29.47
|
-6.64
|
0
|
0
|
-376.28
|
-77.99
|
-5.27
|
-2.56
|
| Operating Income Ratio |
-29.65
|
-6.72
|
0
|
0
|
-385.76
|
-70.16
|
-5.44
|
-2.66
|
| Total Other Income/Expenses Net |
-$302.00 K
|
$4.17 M
|
$6.23 M
|
$1.66 M
|
$1.04 M
|
-$5.75 M
|
-$1.59 M
|
-$745.00 K
|
| Income Before Tax |
-$59.61 M
|
-$69.78 M
|
-$123.46 M
|
-$106.48 M
|
-$95.40 M
|
-$35.85 M
|
-$29.86 M
|
-$28.98 M
|
| Income Before Tax Ratio |
-29.8
|
-6.34
|
0
|
0
|
-381.61
|
-83.57
|
-5.74
|
-2.73
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$204.00 K
|
| Net Income |
-$59.61 M
|
-$69.78 M
|
-$123.46 M
|
-$105.28 M
|
-$95.40 M
|
-$35.85 M
|
-$29.79 M
|
-$28.98 M
|
| Net Income Ratio |
-29.8
|
-6.34
|
0
|
0
|
-381.61
|
-83.57
|
-5.73
|
-2.73
|
| EPS |
-50.5 |
-72 |
-129 |
-137 |
-138 |
-53 |
-46.5 |
-67 |
| EPS Diluted |
-50.5 |
-72 |
-129 |
-137 |
-138 |
-53 |
-46.5 |
-67 |
| Weighted Average Shares Out |
$1.18 M
|
$971.47 K
|
$955.55 K
|
$778.55 K
|
$691.23 K
|
$673.27 K
|
$673.27 K
|
$431.77 K
|
| Weighted Average Shares Out Diluted |
$1.18 M
|
$971.47 K
|
$955.55 K
|
$778.55 K
|
$691.23 K
|
$673.27 K
|
$673.27 K
|
$431.77 K
|
| Link |
|
|
|
|
|
|
|
|
